A detailed history of Oppenheimer Asset Management Inc. transactions in Laboratory Corp Of America Holdings stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 9,540 shares of LH stock, worth $1.93 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
9,540
Previous 10,194 6.42%
Holding current value
$1.93 Million
Previous $2.32 Million 10.02%
% of portfolio
0.03%
Previous 0.03%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$209.01 - $232.56 $136,692 - $152,094
-654 Reduced 6.42%
9,540 $2.08 Million
Q4 2023

Feb 13, 2024

SELL
$197.69 - $227.29 $65,435 - $75,232
-331 Reduced 3.14%
10,194 $2.32 Million
Q3 2023

Nov 07, 2023

BUY
$201.05 - $221.7 $285,491 - $314,814
1,420 Added 15.6%
10,525 $2.12 Million
Q2 2023

Aug 02, 2023

BUY
$211.93 - $241.33 $132,032 - $150,348
623 Added 7.34%
9,105 $2.2 Million
Q1 2023

May 10, 2023

SELL
$213.32 - $257.83 $108,793 - $131,493
-510 Reduced 5.67%
8,482 $1.95 Million
Q4 2022

Feb 06, 2023

BUY
$203.72 - $248.97 $1.29 Million - $1.57 Million
6,323 Added 236.91%
8,992 $2.12 Million
Q3 2022

Nov 14, 2022

BUY
$204.81 - $262.19 $35,227 - $45,096
172 Added 6.89%
2,669 $546,000
Q2 2022

Aug 08, 2022

SELL
$213.86 - $277.87 $48,332 - $62,798
-226 Reduced 8.3%
2,497 $585,000
Q1 2022

May 12, 2022

BUY
$259.82 - $298.18 $34,815 - $39,956
134 Added 5.18%
2,723 $718,000
Q4 2021

Feb 02, 2022

BUY
$271.6 - $314.21 $3,802 - $4,398
14 Added 0.54%
2,589 $814,000
Q3 2021

Nov 12, 2021

BUY
$274.82 - $308.34 $64,033 - $71,843
233 Added 9.95%
2,575 $724,000
Q2 2021

Aug 03, 2021

BUY
$251.87 - $278.14 $55,411 - $61,190
220 Added 10.37%
2,342 $646,000
Q1 2021

May 17, 2021

SELL
$204.88 - $255.03 $113,503 - $141,286
-554 Reduced 20.7%
2,122 $541,000
Q4 2020

Feb 11, 2021

BUY
$186.91 - $214.42 $1,121 - $1,286
6 Added 0.22%
2,676 $545,000
Q3 2020

Nov 13, 2020

SELL
$167.03 - $201.3 $32,069 - $38,649
-192 Reduced 6.71%
2,670 $502,000
Q2 2020

Aug 11, 2020

SELL
$113.31 - $182.44 $41,924 - $67,502
-370 Reduced 11.45%
2,862 $476,000
Q1 2020

May 08, 2020

SELL
$104.32 - $195.28 $16,482 - $30,854
-158 Reduced 4.66%
3,232 $407,000
Q4 2019

Feb 07, 2020

SELL
$163.48 - $173.61 $817 - $868
-5 Reduced 0.15%
3,390 $574,000
Q3 2019

Oct 31, 2019

BUY
$159.77 - $178.1 $46,333 - $51,649
290 Added 9.34%
3,395 $570,000
Q2 2019

Aug 09, 2019

BUY
$144.16 - $172.9 $20,903 - $25,070
145 Added 4.9%
3,105 $537,000
Q1 2019

Apr 24, 2019

BUY
$123.7 - $156.3 $50,964 - $64,395
412 Added 16.17%
2,960 $453,000
Q4 2018

Jan 30, 2019

BUY
$120.82 - $174.09 $78,049 - $112,462
646 Added 33.96%
2,548 $322,000
Q3 2018

Oct 26, 2018

BUY
$167.67 - $188.27 $31,354 - $35,206
187 Added 10.9%
1,902 $331,000
Q2 2018

Aug 10, 2018

BUY
$160.33 - $189.41 $8,337 - $9,849
52 Added 3.13%
1,715 $308,000
Q1 2018

May 09, 2018

BUY
$161.53 - $178.11 $28,913 - $31,881
179 Added 12.06%
1,663 $269,000
Q3 2017

Nov 14, 2017

BUY
$149.47 - $160.56 $221,813 - $238,271
1,484
1,484 $224,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $18.2B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.